2019 Advisory Board

Ms. Gonzalo is a Partner at Oberland Capital, a private investment firm with over $1.2 billion in capital commitments since inception, that is focused exclusively on investing in the global healthcare industry. Prior to joining Oberland, she was a Managing Director at Vatera Healthcare Partners where she focused on venture capital and private equity investments…

Dennis Wahr, MD is the CEO of Nuvaira which is developing a unique minimally invasive bronchoscopic treatment for patients with chronic obstructive lung disease called Targeted Lung Denervation (TLD). Prior to joining Nuvaira, Dr. Wahr co-founded Lutonix in 2007 and served as its President and CEO until CR Bard acquired the company in December 2011.…